Body Composition, Adipocytokine, and Metabolic Parameters in Men With Congenital Hypogonadotropic Hypogonadism
Clinical Endocrinology · 2025
DOI: 10.1111/cen.15189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Rui Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical Colle…. Hauptthemen laut MEDLINE: Hypogonadism, Body Composition, Adipokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: This work was supported by the Project of National Natural Science Foundation of China (81771576, 81971375); the Beijing Municipal Natural Science Foundation (….
Abstract (Originalsprache)
Objective
This study aimed to evaluate the long‐term effects of hormone therapies on the body composition, adipokines and metabolic parameters of adult men with congenital hypogonadotropic hypogonadism (CHH).
Methods
Sixty‐six patients with CHH and 21 healthy controls were recruited. Patients were divided into untreated ( n = 33) and treated ( n = 33) groups based on hormone therapy history. Body composition was assessed using dual‐energy X‐ray absorptiometry (DXA), and adipokines and metabolic parameters were measured in all participants.
Results
Compared to the healthy control group, patients in the treated group had lower serum testosterone levels ( p < 0.001), increased body fat percentage (BFP) and visceral adipose tissue (VAT) volume, decreased lean soft tissue (LST) and bone mineral content (BMC) ( p < 0.05), increased serum leptin levels accompanied by decreased adiponectin (ADP) ( p < 0.05), higher HOMA‐IR with lower QUICKI ( p < 0.05). Compared to the untreated group, patients in the treated group (therapy duration 4.8 ± 2.3 years) had higher serum testosterone levels ( p < 0.001), decreased BFP and VAT volume, increased LST and BMC ( p < 0.05), decreased serum leptin levels ( p < 0.001), and decreased HOMA‐IR accompanied by increased QUICKI ( p < 0.05). Among them, VAT volume, LST, BMC, HOMA‐IR and QUICKI reached healthy control levels ( p > 0.05). Multiple stepwise linear regression analysis showed serum testosterone levels were negatively correlated with BFP ( β = −0.564, p < 0.001) and VAT volume ( β = −0.260, p = 0.045), positively correlated with LST ( β = 0.305, p = 0.018) and BMC ( β = 0.423, p = 0.001). Serum testosterone levels were independently negatively correlated with leptin levels ( β = −0.277, p = 0.004).
Conclusions
Patients with untreated CHH had impaired body composition, adipokines and metabolic parameters. While hormone therapies can improve body composition and glucolipid metabolism in patients with CHH, this imperfect treatment does not fully rescue body composition abnormalities when compared to healthy individuals. Abnormal metabolic parameters in patients with CHH are associated with increased fat mass and abnormal serum leptin level. Serum testosterone levels were independently negatively correlated with leptin levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Health Management, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
- Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
- Department of Ultrasonography, Peking University First Hospital, Beijing, China.
Förderung
- This work was supported by the Project of National Natural Science Foundation of China (81771576, 81971375); the Beijing Municipal Natural Science Foundation (…
Zitieren
APA
Zhang, R., Mao, J., Nie, M., Wang, X., Xu, T., Chen, F., Song, A., Hu, Y., Yu, B., Huang, Q., Sun, B., Zhang, W., Zhang, J., Lin, S., & Wu, X. (2025). Body Composition, Adipocytokine, and Metabolic Parameters in Men With Congenital Hypogonadotropic Hypogonadism. Clinical Endocrinology. https://doi.org/10.1111/cen.15189
Vancouver
Zhang R, Mao J, Nie M, Wang X, Xu T, Chen F, et al. Body Composition, Adipocytokine, and Metabolic Parameters in Men With Congenital Hypogonadotropic Hypogonadism. Clinical Endocrinology. 2025. doi:10.1111/cen.15189
BibTeX
@article{Zhang2025,
author = {Zhang, Rui and Mao, Jiangfeng and Nie, Min and Wang, Xi and Xu, Tengda and Chen, Fengling and Song, Ailing and Hu, Yingying and Yu, Bingqing and Huang, Qibin and Sun, Bang and Zhang, Wei and Zhang, Junyi and Lin, Songbai and Wu, Xueyan},
title = {Body Composition, Adipocytokine, and Metabolic Parameters in Men With Congenital Hypogonadotropic Hypogonadism},
journal = {Clinical Endocrinology},
year = {2025},
doi = {10.1111/cen.15189}
}
EUVIMED